NASDAQ:IVF INVO Fertility Q4 2025 Earnings Report $0.97 0.00 (0.00%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.94 -0.03 (-3.30%) As of 04:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast INVO Fertility EPS ResultsActual EPS$4.18Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AINVO Fertility Revenue ResultsActual Revenue$1.60 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AINVO Fertility Announcement DetailsQuarterQ4 2025Date6/2/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile INVO Fertility Earnings HeadlinesINVO Fertility, Inc (NASDAQ:IVF) Short Interest Up 60.9% in AugustSeptember 19 at 4:21 AM | americanbankingnews.comHead-To-Head Review: Hinge Health (NYSE:HNGE) versus INVO Fertility (NASDAQ:IVF)September 18 at 4:15 AM | americanbankingnews.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under. | Paradigm Press (Ad)INVO Fertility Announces Equity Financing and Capital CommitmentAugust 29, 2026 | theglobeandmail.comINVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment ConferenceAugust 28, 2026 | globenewswire.comINVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium InternationalAugust 20, 2026 | globenewswire.comSee More INVO Fertility Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Fertility? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Fertility and other key companies, straight to your email. Email Address About INVO FertilityINVO Fertility (NASDAQ:IVF). is a medical technology and fertility services company focused on expanding access to in vitro fertilization (IVF) and related assisted reproductive technologies. The company’s primary product is INVOcell, an intravaginal culture system designed to incubate eggs and embryos inside a woman’s body during part of the IVF process, under the supervision of a fertility professional. INVO Fertility seeks to make fertility treatment more accessible through a combination of medical devices, clinical services, and fertility centers. Its business model includes commercializing INVOcell, supporting clinics that use the technology, and developing or operating fertility treatment centers that provide services such as evaluation, egg retrieval, embryo culture, and embryo transfer. The company was formerly known as INVO Bioscience and adopted the INVO Fertility name as it expanded its focus beyond device commercialization toward a broader fertility-care platform. INVOcell has received regulatory clearance in the United States and is also marketed in selected international markets, subject to applicable regulatory requirements. The company’s activities have primarily centered on the United States, with additional commercial and clinical opportunities pursued internationally.View INVO Fertility ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushGold Has Gone Sideways, But These 3 Stocks Haven’tLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in Focus Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
